These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 19023877

  • 21. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
    Chinen Y, Taki T, Nishida K, Shimizu D, Okuda T, Yoshida N, Kobayashi C, Koike K, Tsuchida M, Hayashi Y, Taniwaki M.
    Oncogene; 2008 Apr 03; 27(15):2249-56. PubMed ID: 17968322
    [Abstract] [Full Text] [Related]

  • 22. DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
    Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B, Parry A, Walz C, Wiemels JL, Segal MR, Adès L, Blair IA, Osheroff N, Peniket AJ, Lafage-Pochitaloff M, Cross NC, Chomienne C, Solomon E, Fenaux P, Grimwade D.
    N Engl J Med; 2005 Apr 14; 352(15):1529-38. PubMed ID: 15829534
    [Abstract] [Full Text] [Related]

  • 23. NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
    Nebral K, Schmidt HH, Haas OA, Strehl S.
    Clin Cancer Res; 2005 Sep 15; 11(18):6489-94. PubMed ID: 16166424
    [Abstract] [Full Text] [Related]

  • 24. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
    Wichmann C, Chen L, Heinrich M, Baus D, Pfitzner E, Zörnig M, Ottmann OG, Grez M.
    Cancer Res; 2007 Mar 01; 67(5):2280-9. PubMed ID: 17332359
    [Abstract] [Full Text] [Related]

  • 25. A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22).
    Abe A, Katsumi A, Kobayashi M, Okamoto A, Tokuda M, Kanie T, Yamamoto Y, Naoe T, Emi N.
    Cancer Genet; 2012 Nov 01; 205(11):608-11. PubMed ID: 23102734
    [Abstract] [Full Text] [Related]

  • 26. Immunophenotypic profile predictive of KIT activating mutations in AML1-ETO leukemia.
    De J, Zanjani R, Hibbard M, Davis BH.
    Am J Clin Pathol; 2007 Oct 01; 128(4):550-7. PubMed ID: 17875504
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
    Yang G, Khalaf W, van de Locht L, Jansen JH, van der Reijden BA, Müller-Tidow C, Delwel HR, Serve H, Clapp DW, Hiebert SW.
    Ann Hematol; 2004 Jun 01; 83(6):329-30. PubMed ID: 15052372
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P, Villa O, Alfaro EM, Alonso CN, Baro C, Felice MS, Rossi J, Solé F, Gallego MS.
    Pediatr Blood Cancer; 2008 Mar 01; 50(3):651-4. PubMed ID: 17405156
    [Abstract] [Full Text] [Related]

  • 34. Identification of RUNX1/AML1 as a classical tumor suppressor gene.
    Silva FP, Morolli B, Storlazzi CT, Anelli L, Wessels H, Bezrookove V, Kluin-Nelemans HC, Giphart-Gassler M.
    Oncogene; 2003 Jan 30; 22(4):538-47. PubMed ID: 12555067
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia.
    Tosi S, Ballabio E, Teigler-Schlegel A, Boultwood J, Bruch J, Harbott J.
    Genes Chromosomes Cancer; 2005 Nov 30; 44(3):225-32. PubMed ID: 16028218
    [Abstract] [Full Text] [Related]

  • 37. The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1.
    Parker H, An Q, Barber K, Case M, Davies T, Konn Z, Stewart A, Wright S, Griffiths M, Ross FM, Moorman AV, Hall AG, Irving JA, Harrison CJ, Strefford JC.
    Genes Chromosomes Cancer; 2008 Dec 30; 47(12):1118-25. PubMed ID: 18767146
    [Abstract] [Full Text] [Related]

  • 38. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
    Li X, Xu YB, Wang Q, Lu Y, Zheng Y, Wang YC, Lübbert M, Zhao KW, Chen GQ.
    J Cell Physiol; 2006 Sep 30; 208(3):594-601. PubMed ID: 16741927
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.